We are committed to reshaping the landscape of healthcare innovation and business expansion.
Our mission is to leverage our extensive expertise and global reach to empower healthcare companies across the world, offering a comprehensive suite of services that drive growth and success.
{
{
About
Strong vision and leadership
Our company is founded on the vision and leadership of Bjoern von Siemens, a seasoned professional with a proven track record in healthcare business development and a passion for improving healthcare outcomes. Bjoern's journey is a blend of professional excellence, personal dedication, and a strong commitment to making a difference in the healthcare industry. This unique blend of experiences has driven the establishment of VSiemens as a leader in the field.
Bjoern Von Siemens
About
Björn von Siemens is a force in the intersection of healthcare and technology, coming from a lineage of tech industrialists and medical pioneers. His deep-rooted passion for leveraging technology to address healthcare challenges has been a cornerstone of his illustrious career. As the founder of Caresyntax and Surgical.AI, Björn has taken significant strides in applying IoT and AI to healthcare, with both companies aimed at revolutionizing surgical care and healthcare systems globally.
Vast business experience
Before embarking on his entrepreneurial journey, Björn gained extensive experience in top-tier organizations such as Siemens, Boston Consulting Group (BCG), Bain & Company, and within the mid-cap private equity sector. His business acumen also led him to found a biotech company, which he successfully exited to Munich Venture Partners. Today, aside from his operational roles, Björn is actively involved in healthcare technology ventures as an investor and advisor, where his insights are highly valued.
Shaping the future
A recognized thought leader, Björn's expertise spans applied IoT and AI technologies in healthcare. He has been instrumental in shaping the conversation around innovation in surgical and healthcare technology, reflecting his status as a respected voice in the field.
Education
Björn's academic credentials are as impressive as his professional ones. He holds an M.Sc. in Accounting and Finance from the London School of Economics and a B.Sc. from the European Business School. Further demonstrating his commitment to lifelong learning and research, he has spent several years engaged in postgraduate research at the University of St. Gallen and has also conducted studies at Harvard University and Harvard Business School.
Investing
With over $500 million managed in investments across various entities, Björn's impact extends far beyond the companies he has founded. His strategic investments in healthcare technology ventures have not only shown his knack for identifying potential but have also contributed significantly to advancing the industry. Björn von Siemens represents the synthesis of entrepreneurial spirit, executive leadership, and scholarly dedication, continually driving forward the boundaries of healthcare innovation.
Pioneers from Goslar to the World
Our story begins with Ananias Siemens, a 16th-century brewer and oil mill owner, and spans centuries to his descendants, who transformed the landscape of technology and engineering. The Siemens family has not only contributed significantly to the city's governance with multiple members serving as mayors but has also profoundly impacted the global technological sphere.
In 1847, Werner Siemens, an artillery officer turned inventor, alongside Johann Georg Halske, founded what would become a cornerstone of global technology: Siemens. From the first long-distance telegraph line in Europe to the pioneering advancements in telegraphy and electrical engineering, Siemens has been at the forefront of innovation. The launch of such monumental projects as the Indo-European telegraph line and the first electric street lighting powered by a Siemens AC Alternator marked milestones in technological progress.
The contributions of the Siemens family have been recognized by nobility titles across Europe, from Werner Siemens’ ennoblement as von Siemens by Frederick III, German Emperor, to his brother William’s knighthood by Queen Victoria. Their legacy is not merely in their inventions but also in their leadership and vision, propelling Siemens to become a leader in not just industrial but also medical technologies, as seen with the formation of Siemens-Reiniger-Werke AG.
A Legacy of Leadership and Vision
Today, the Siemens family continues to influence the company with a minority ownership that ensures stability and adherence to a legacy of innovation. The family’s commitment is reflected in their ongoing presence in the company's supervisory board, ensuring that Siemens remains at the forefront of technological advancement.
The Siemens Family Legacy
The Siemens family, a name synonymous with innovation and excellence in technology and telecommunications, traces its noble roots back to 1384 in the Free Imperial City of Goslar, Lower Saxony. The family began with Henning Symons, and through the generations, it has been intimately linked with the pioneering of global industry and remains the largest shareholder of Siemens AG today.
Advisors
David Cubbin
David is a highly skilled investment executive, currently leading as the Chief Executive Officer at Cure Capital Advisors, a position he assumed in April 2023. Based across Dubai, London, and Sydney, his expertise is further utilized as a Director and Advisor for a Single Family Office in London. With a strong track record in business development and fund management at Fidante Partners and Challenger Limited, David has demonstrated his prowess in raising funds and developing strategic partnerships. His entrepreneurial spirit is evidenced by his founding of SCOOP Connect, establishing it as a key ISP in South Sudan. David's ability to analyze and pitch innovative investment solutions is backed by his experience with Private Capital Management Ltd and his analytical role at Macquarie Group. His global experience and strategic insights make him a dynamic leader in the healthcare investment industry.
He holds an MSc in Finance and Accounting from The London School of Economics and Political Science (LSE), where he graduated with distinction.
David Barnit
David Barnitt, the founder and President of Attract Capital, is a seasoned entrepreneur and finance expert with a 25-year career encompassing over 125 transactions worth $1.2 billion. His expertise in private debt and mergers and acquisitions has been honed at top firms like Ernst & Young and JP Morgan Chase. Renowned for his insights in mezzanine financing, Mr. Barnitt is a respected speaker and educator, conducting seminars and webinars with major financial institutions. He holds an accounting degree from Georgetown University and an MBA in Finance from Columbia Business School, blending academic knowledge with extensive practical experience.
What do healthcare professionals say about Bjoern?
As a visionary yet down to earth leader, Bjoern works extremely hard himself and attempts to help our team see beyond the immediate challenges. What stands out is Bjoern 's entrepreneurial endurance, a quality that helps caresyntax overcome obstacles with determination and creativity.
Etienne Bauer
Senior Vice President at Caresyntax
Bjoern is a genuinely warm and approachable individual. He is a good communicator and a natural networker, building strong relationships with partners, clients, and colleagues alike. He cares about people. I am inspired working alongside Bjoern at Caresyntax, and I wholeheartedly endorse him as a colleague and leader.
Amel Mokrani Bois
Senior Vice President, Commercial Europe Caresyntax
In the last 4 years that I have known Bjoern, he has shown himself to be an exceptional leader and entrepreneur. He seamlessly wears multiple hats of Co-Founder, Chief Business Officer and Chief Finance Officer, and does that with grace and humor. Bjoern is very result oriented and wants to quantify the impact of making surgery safer and smarter
Vik Anantha
Alex M. Kis, CFA, is a healthcare investment professional with deep expertise in advancing health technology and innovation through venture capital. As a Founding Partner at Blue Shield Partners in London, he specializes in fundraising for emerging startups and investing in transformative health technologies. Alex has a track record of success in corporate finance roles at Caresyntax and Surgical.AI and has made significant contributions to healthcare investments at ING and Barclays Investment Bank.
Educationally, Alex is an MBA candidate at the Yale School of Management and holds a summa cum laude degree from Northeastern University. His analytical prowess is further endorsed by his membership in American Mensa and his Chartered Financial Analyst certification. With a strong professional network, Alex is recognized for his insightful perspectives on healthcare finance and his commitment to fostering innovation for improved patient outcomes.
Alex Kis
Pioneers from Goslar to the World